SUMMARY A questionnaire was circulated to clinical biochemistry laboratories in the North West Thames region of the United Kingdom requesting information on extralaboratory equipment. Data on the types and numbers of instruments in use, their relationship with the laboratory, and quality assurance procedures were obtained. Laboratories were prepared to maintain equipment over which they had no responsibility for purchase, training of users, or use. The quality assurance of these instruments gave even greater cause for concern. Although internal quality control procedures were performed on many of the instruments, laboratories were involved in only a minority of these procedures. Quality control procedures and training ofusers were undertaken on site in less than 50% of blood gas analysers and bilirubin meters and in less than 25% of glucose meters. External quality assessment procedures were non-existent for all ofthe instruments in use with the exception ofglucose stick meters in two laboratories. There has been widespread concern expressed both by individuals and professional bodies regarding the analytical quality ofresults obtained from instruments used outside clinical biochemistry laboratories by non-laboratory staff. Several publications have documented their poor performance and the inferior quality of results obtained using these techniques.'
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Much effort has been invested by members of the profession, both in the United Kingdom and abroad, in establishing guidelines on analyses outside the laboratory.' Commercial development of a wide range of instruments capable of chemical, haematological, microbiological and immunological tests seems likely to ensure that this trend towards extra-laboratory testing will continue. It is not clear from the published guidelines with whom the responsibility for quality of performance lies, nor who will bear the cost consequences of funding extralaboratory testing, but it is essential that professional laboratory staff become involved with all aspects of this new growth area of clinical practice.
We therefore felt it an appropriate time to determine the number and types of instruments in use in the North West Thames region and the current involvement of clinical biochemistry laboratories in the purchase, training, maintenance and quality assurance of such instruments. This paper describes the results of a questionnaire designed to answer these problems. It should be emphasised that the aim of this study was not to analyse the quality of results produced by such instruments nor to argue the Burrin, Fyffe instruments despite the laboratory being responsible for the maintenance of 12 ofthem and also the running costs in two instances. Twenty one analysers are quality controlled internally, 15 by the laboratory. None ofthe instruments was entered into any extemal quality assessment scheme. In most hospitals their purchase had changed the workload.
BILIRUBIN METERS
All of the hospitals except three have bilirubin meters in used outside the laboratory (table 3) . Most of these instruments are located in special care baby units where they are used by members of the paediatric department and medical or nursing staff. In only one instance had the laboratory been involved in training and retained responsibility for the meter and its maintenance. In most cases the running costs were borne by the paediatric department. Six of the 13 meters were quality controlled internally and the laboratory was usually involved in this. In most cases the presence of these instruments had changed the workload of the laboratory.
OTHER INSTRUMENTS
There is one Reflotron (Boehringer, Mannheim, West Germany) in use in the region outside the laboratory. The laboratory was involved in the purchase of this instrument and is responsible for the maintenance, training, running costs and internal quality control procedures. The laboratory's workload for urea, glucose, and haemoglobin estimate had been changed since the purchase of this instrument. Four hospitals in the region have six instruments for the measurement of sodium and potassium. In most cases the instruments are maintained and internally quality controlled by the laboratory, although only one laboratory had been involved in training the users who were mainly medical staff of the anaesthetic department. None of the instruments, however, was externally quality assessed despite the change in the laboratories' workload. A few other types of instruments such as osmometers were in use outside laboratories. Although these instruments tended to be internally quality controlled, none has entered into external quality assessment schemes, and in most cases the laboratory was not involved in their maintenance, training, purchase or running costs.
Discussion
Clinical biochemistry laboratories can no longer ignore the problem of analytical equipment in use outside the laboratory. The replies to our questionnaire have indicated the large numbers of instruments in use and the wide range of analyses concerned. It is alarming to note that laboratories were prepared to maintain equipment over which they had no responsiblity for purchase, use, or training.
The quality assurance of these instruments gives even greater cause for concern. Although internal quality control procedures are stated to be performed on some ofthe equipment, laboratories are involved in only a minority of these procedures. Often the quality assessment samples are analysed by laboratory staff when doing routine maintenance rather than as true quality assessment samples run by users of the instrument. Entry into external quality assessment schemes was non-existent, with the exception of glucose meters in two laboratories. It is tempting to speculate that the poor performance of extralaboratory equipment reported'4 is related to this.
In many instances laboratories felt that their workload had been changed by the introduction of extra-laboratory equipment. The cost effectiveness of transferring analyses from the laboratory, however, is an area which requires more detailed investigation. We feel that the data obtained in the North West Thames region from this questionnaire are representative of the other health regions in the United Kingdom. The results show the enormous scale of the problem, which requires the urgent attention of all clinical biochemists.
